Jones Financial Companies
STLN

Jones Financial Companies’s Starling Oncology STLN Stock Holding History

Jones Financial Companies’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.12K Hold
578
– – ﹤0.01% 4282
2026
Q1 		$1.71K Buy
+578
New +$1.77K ﹤0.01% 4195

Other funds holding STLN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Jones Financial Companies's STLN Position: Q2 2026 in Review

Jones Financial Companies held its Starling Oncology (STLN) position steady in Q2 2026 at 578 shares worth $3.12K. The position accounts for ﹤0.01% of the portfolio, ranked #4282.

Jones Financial Companies first reported a position in STLN in Q1 2026 and has held it in 2 quarters since. 119 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • Jones Financial Companies held 578 shares of Starling Oncology worth $3.12K as of Q2 2026.
  • Jones Financial Companies left its Starling Oncology share count unchanged in Q2 2026.
  • Starling Oncology made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4282 holding.
  • Jones Financial Companies first reported a position in Starling Oncology in Q1 2026 and has held it in 2 quarters since.
  • 119 funds tracked by Wall St. Rank held Starling Oncology as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.